A rating of 79 puts Reata Pharmaceuticals Inc (RETA) near the top of the Biotechnology industry according to InvestorsObserver. Reata Pharmaceuticals Inc's score of 79 means it scores higher than 79% of stocks in the industry. Reata Pharmaceuticals Inc also received an overall rating of 48, putting it above 48% of all stocks. Biotechnology is ranked 107 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 48 would rank higher than 48 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Reata Pharmaceuticals Inc Stock Today?
Reata Pharmaceuticals Inc (RETA) stock is trading at $139.24 as of 2:03 PM on Monday, Jun 21, a rise of $1.24, or 0.9% from the previous closing price of $138.00. The stock has traded between $136.00 and $140.06 so far today. Volume today is low. So far 184,974 shares have traded compared to average volume of 556,346 shares.
Click Here to get the full Stock Score Report on Reata Pharmaceuticals Inc (RETA) Stock.
